Literature DB >> 8148686

Myxoedema revealed by simvastatin induced myopathy.

M A al-Jubouri1, P G Briston, D Sinclair, R H Chinn, R M Young.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8148686      PMCID： PMC2539565          DOI： 10.1136/bmj.308.6928.588

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  [Does hypothyroidism potentialize muscular toxicity of fibrates?].

Authors:  J R Harlé; E Toussirot; P Disdier; M Drancourt; P J Weiller
Journal:  Rev Med Interne       Date:  1990 Jul-Aug       Impact factor: 0.728

2.  [Toxic myopathy due to hypolipemic agents].

Authors:  P Bourrier; J F Subra; J M Chennebault; R Spiesser; P Laine
Journal:  Therapie       Date:  1990 Jul-Aug       Impact factor: 2.070

3.  The incidence of asymptomatic hypothyroidism in new referrals to a hospital lipid clinic.

Authors:  M J O'Kane; R D Neely; E R Trimble; D P Nicholls
Journal:  Ann Clin Biochem       Date:  1991-09       Impact factor: 2.057

4.  Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin.

Authors:  D J Norman; D R Illingworth; J Munson; J Hosenpud
Journal:  N Engl J Med       Date:  1988-01-07       Impact factor: 91.245

5.  Nicotinic acid-associated myopathy: a report of three cases.

Authors:  S C Litin; C F Anderson
Journal:  Am J Med       Date:  1989-04       Impact factor: 4.965

6.  [Rhabdomyolysis under treatment by ciprofibrate in the nephrotic syndrome].

Authors:  A Baglin; N Lasserre; J Prinseau; M Lebas
Journal:  Therapie       Date:  1987 Mar-Apr       Impact factor: 2.070

7.  Plasma enzyme activities in primary hypothyroidism.

Authors:  G H White; R N Walmsley
Journal:  Clin Chem       Date:  1984-02       Impact factor: 8.327

8.  Clofibrate-induced muscle damage in patients with chronic renal failure.

Authors:  A M Pierides; F Alvarez-Ude; D N Kerr
Journal:  Lancet       Date:  1975-12-27       Impact factor: 79.321
  8 in total
  7 in total

1.  [Unnoticed hypothyroidism and myopathy due to lipid-lowering drugs].

Authors:  G Gascón Ramón; F Bertomeu Blanch; V Meneu Montoliu; M D Fenollosa Tamarit
Journal:  Aten Primaria       Date:  2001-04-15       Impact factor: 1.137

2.  [Myopathy linked to statins in a patient with recently appeared hypothyroidism].

Authors:  C León Rodríguez; M Martínez González
Journal:  Aten Primaria       Date:  2005 Jul-Aug       Impact factor: 1.137

Review 3.  [Diagnostics and treatment of statin-associated muscle symptoms].

Authors:  Ursula Kassner; Stefanie Grunwald; Dominik Spira; Nikolaus Buchmann; Thomas Bobbert; Elisabetta Gazzerro; Tim Hollstein; Simone Spuler; Elisabeth Steinhagen-Thiessen
Journal:  Internist (Berl)       Date:  2021-06-18       Impact factor: 0.743

4.  Rhabdomyolysis from tourniquet trauma in a patient with hypothyroidism.

Authors:  P L Vold; P J Weiss
Journal:  West J Med       Date:  1995-03

5.  Hyperlipidaemia and hypothyroidism. Screen patients for hypothyroidism before treatment.

Authors:  A O Olukoga; V E Crowley; A Lawal; C Weinkove
Journal:  BMJ       Date:  1994-04-02

Review 6.  Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy.

Authors:  Pierandrea Vinci; Emiliano Panizon; Letizia Maria Tosoni; Carla Cerrato; Federica Pellicori; Filippo Mearelli; Chiara Biasinutto; Nicola Fiotti; Filippo Giorgio Di Girolamo; Gianni Biolo
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

Review 7.  Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components.

Authors:  Richard Myles Turner; Munir Pirmohamed
Journal:  J Clin Med       Date:  2019-12-20       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.